Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology operates in the dental and orthodontic medical device sector, where news typically centers on product innovations, clinical study results, regulatory approvals, and quarterly financial performance. The company's announcements often involve new features for the Invisalign clear aligner system, updates to iTero scanner technology, and expansion into new geographic markets or treatment applications.
Investors and dental professionals following Align Technology track earnings reports that break down Clear Aligner segment performance versus Scanner and Services revenue. These reports reveal trends in case volume, average selling prices, and adoption rates among orthodontists versus general practitioner dentists. The company also announces clinical partnerships, research collaborations, and professional education initiatives that affect market penetration.
Product launch announcements detail new aligner systems designed for specific patient populations or clinical scenarios, while scanner updates often involve new software capabilities or imaging improvements. Regulatory filings and approvals in international markets signal geographic expansion opportunities. The company occasionally discloses intellectual property developments, including patent grants and litigation related to clear aligner technology.
This news feed provides access to material announcements affecting Align Technology's business operations, competitive position, and financial results. Monitor this page for developments that may influence the company's market share in orthodontic treatment and digital dental imaging.
Align Technology (Nasdaq: ALGN) will report Q4 and full-year 2025 results on Wednesday, February 4, 2026 after market close. Financial results will be released at 4:00 p.m. ET and a conference call will follow at 4:30 p.m. ET, available via live audio webcast on the company Investor Relations site. An archived webcast will be posted about two hours after the call and remain available for one month.
Align also published anticipated 2026 quarterly earnings dates (Q1'26 Apr 29; Q2'26 Jul 29; Q3'26 Oct 28; Q4'26 Feb 3, 2027) and reiterated operating scope: ~291.0 thousand doctor customers, ~21.4 million patients treated, and a 600 million consumer market opportunity.
Align Technology (Nasdaq: ALGN) announced commercial availability of the Invisalign System with mandibular advancement featuring occlusal blocks in Thailand and across multiple APAC markets. The product is Align’s first clear aligner with integrated solid occlusal blocks designed to deliver predictable mandibular advancement while simultaneously aligning teeth for growing patients in the late mixed to early permanent dentition (ages 10–16).
Key features include solid laser‑welded occlusal blocks for durability and vertical opening, earlier mandibular advancement for deep‑bite cases, SmartTrack™ material for comfort, allowance of attachments under blocks, and regional commercial availability in Australia, New Zealand, Japan, Hong Kong, Malaysia, Singapore, India, Korea, China, Vietnam, Philippines and Thailand.
Align Technology (NASDAQ: ALGN) highlighted its Align Digital Platform innovations at the Greater New York Dental Meeting 2025 on December 3, 2025, showcasing hardware, software, and clinical education for dental professionals.
Key demos included the iTero Lumina scanner with Multi-Direct Capture and larger field of view, Invisalign Smile Architect with Multiple Treatment Plans, ClinCheck Signature global rollout, iTero Design Suite for in-practice 3D printing, Align Oral Health Suite, and exocad DentalCAD 3.3 Chemnitz with upgraded Implant Module and AI-enabled multi-unit design.
Align Technology (Nasdaq: ALGN) was named Most Honored Company in Extel Insights' 2025 All-America Executive Team rankings and earned multiple #1, #3 and top-10 placements across leadership, board, investor relations, and investor/analyst event categories.
Key recognitions included Best CEO Joseph Hogan (#1 Large-Cap, #3 sector), Best CFO John Morici (#1 Large-Cap, #3 sector), Best Company Board (#1 Large-Cap), and top rankings for the IR program, IR team, IR professionals, and investor/analyst event. The awards mark Align's third Extel recognition in four years.
Align Technology (Nasdaq: ALGN) announced commercial availability on November 25, 2025 of the Invisalign System with mandibular advancement featuring occlusal blocks for growing patients.
The product targets ages 10–16, combines mandibular advancement with tooth alignment in one appliance, uses solid laser‑welded occlusal blocks and SmartTrack™ material for durability and comfort, and enables earlier mandibular advancement in deep‑bite Class II cases. Initial commercial rollout covers multiple APAC markets including the Philippines, Australia, Japan, China, India and others.
Align Technology (Nasdaq: ALGN) will present at four upcoming financial conferences in November–December 2025: UBS Global Healthcare (Nov 11), Jefferies Healthcare (Nov 18), Piper Sandler Healthcare (Dec 2), and Evercore Healthcare (Dec 3). Senior executives scheduled to speak include Joe Hogan (President & CEO), John Morici (EVP Global Finance and CFO), and other senior finance and investor relations leaders.
All presentations will be webcast live via the Investor Relations site at http://investor.aligntech.com, with archived replays available on the site for approximately one month.
Align Technology (NASDAQ: ALGN) opened its 2026 Annual Research Award Program offering up to $300,000 in total funding to support clinical and scientific dental research at universities worldwide. Individual regional awards include four one-year grants up to $25,000 each for Americas, EMEA, and APAC. The program has funded approximately $3.96 million since 2010. Applications are due by 5:00 p.m. PT on March 6, 2026, and awardees will be notified by June 1, 2026.
Eligible applicants are university faculty where Invisalign or iTero is available; selections follow independent academic review and Align’s final decision.
Align Technology (NASDAQ: ALGN) announced a suite of iTero Digital Solutions innovations on October 29, 2025 that expand chairside visualization, design and production workflows to boost patient engagement and treatment conversion.
Key features include the Align Oral Health Suite, Patient Gallery, simplified Oral Health Reports with QR sharing, Invisalign Outcome Simulator Pro with Smile Video (claimed to double chairside conversion for general dentistry), expanded iTero Design Suite compatibility with many 3D printers and mills, a new mock-up workflow for single-visit dentistry, and premium training and support.
New tools are globally available subject to regional regulatory approvals; Invisalign Outcome Simulator Pro availability is limited to iTero Element Plus Series and the company cites >115,000 simulations to date.
Align Technology (NASDAQ: ALGN) announced ClinCheck Live Plan, a new ClinCheck feature that automates initial Invisalign treatment plans and returns a doctor-ready 3D plan in about 15 minutes. Built on Align’s proprietary data and algorithms and experience from >21 million Invisalign patients, the system applies a doctor’s pre-configured preferences and runs quality checks after a Flex Rx submission and iTero scan. Align says ClinCheck Live Plan can shorten planning from days to minutes, enable in‑office plan approval, and improve office efficiency and patient experience. Global roll‑out is planned to begin in Q1 2026 with training resources provided.
FAQ
What is the current stock price of Align Technology (ALGN)?
What is the market cap of Align Technology (ALGN)?
